Chronic hepatitis B virus (HBV) infection affects about 296 million people worldwide and is
the leading aetiology of cirrhosis and liver cancer globally. Major medical complications also …

Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide.
Surveillance for HCC is critical for early detection and treatment, but fewer than one-quarter …

Liver cancer epidemiology is changing due to increasing alcohol consumption, rising
prevalence of obesity, and advances in hepatitis B virus (HBV) and hepatitis C virus (HCV) …

To facilitate the achieving of the goal of" eliminating viral hepatitis as a major public health
threat by 2030" set by the World Health Organization, the Chinese Society of Hepatology …

Hepatology AASLD Publications Hepatology Liver Transplantation Hepatology
Communications Clinical Liver Disease Log in or Register Subscribe to journalSubscribe …

Globally, nearly half of deaths from cirrhosis and chronic liver diseases (CLD) and three-
quarters of deaths from hepatocellular carcinoma (HCC) occur in the Asia-Pacific region …

Antiviral therapy substantially reduces HCC risk in patients... : Hepatology Antiviral therapy
substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate …

Background Many patients with chronic hepatitis B (CHB) do not meet the definitions of the
traditional natural phases and are classified as being in the grey zone (GZ). Aims To …

The hepatitis B virus (HBV) is a major cause of cirrhosis and hepatocellular carcinoma
worldwide. Despite an effective vaccine, the prevalence of chronic infection remains high …

Hepatitis B virus (HBV) is responsible for more than 50% of hepatocellular carcinoma (HCC)
in HBV hyperendemic areas, such as the Asia-Pacific region. Several hepatitis B viral factors …